BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24851355)

  • 1. [Levothyroxine and generics: current reflections].
    Orgiazzi J; Wémeau JL
    Rev Prat; 2014 Mar; 64(3):304-6. PubMed ID: 24851355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preventable problems in thyroid hormone substitution therapy. The risks of brand change are unpredictable].
    MMW Fortschr Med; 2010 Jun; 152(22):46-7. PubMed ID: 20590034
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prescribing levothyroxine. Preparation hopping risks accurate regulation].
    MMW Fortschr Med; 2009 Mar; 151(12):37. PubMed ID: 19475856
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary hypothyroidism: Considerations for a rational use of levothyroxine therapy].
    Bros JA; Lluís PG; Cabot GL; Pedragós AC
    Med Clin (Barc); 2011 Feb; 136(5):207-14. PubMed ID: 19646718
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic levothyroxine.
    Med Lett Drugs Ther; 2004 Sep; 46(1192):77-8. PubMed ID: 15452463
    [No Abstract]   [Full Text] [Related]  

  • 7. Generic vs name brand L-thyroxine products: interchangeable or still not?
    Hennessey JV
    J Clin Endocrinol Metab; 2013 Feb; 98(2):511-4. PubMed ID: 23390262
    [No Abstract]   [Full Text] [Related]  

  • 8. Two cases of therapeutic failure associated with levothyroxine brand interchange.
    Copeland PM
    Ann Pharmacother; 1995 May; 29(5):482-5. PubMed ID: 7655130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status of the treatment with thyroid hormones].
    Laudo Pardos C; Puigdevall Gallego V; del Río Mayor MJ; Velasco Martín A
    An Med Interna; 1996 Nov; 13(11):555-61. PubMed ID: 9019218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levothyroxine malabsortion].
    Catalina PF; Carpio D
    Med Clin (Barc); 2015 Jul; 145(1):46. PubMed ID: 25458511
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid storm.
    Rennie D
    JAMA; 1997 Apr; 277(15):1238-43. PubMed ID: 9103350
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide.
    Sperber AD; Liel Y
    Arch Intern Med; 1992 Jan; 152(1):183-4. PubMed ID: 1728914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption and buccal absorption of liquid levothyroxine.
    Benvenga S; Di Bari F
    Endocrine; 2017 Dec; 58(3):591-594. PubMed ID: 28271396
    [No Abstract]   [Full Text] [Related]  

  • 14. Levothyroxine in psychiatry: issues related to absorption after oral dosing.
    Andrade C
    J Clin Psychiatry; 2013 Aug; 74(8):e744-6. PubMed ID: 24021514
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioequivalence of generic preparations of levothyroxine.
    Toft A
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):603; author reply 603-4. PubMed ID: 19508682
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene.
    Garwood CL; Van Schepen KA; McDonough RP; Sullivan AL
    Pharmacotherapy; 2006 Jun; 26(6):881-5. PubMed ID: 16716142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
    Green WL
    AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism.
    Shakir KM; Chute JP; Aprill BS; Lazarus AA
    South Med J; 1997 Jun; 90(6):637-9. PubMed ID: 9191742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism.
    Alexander EK; Marqusee E; Lawrence J; Jarolim P; Fischer GA; Larsen PR
    N Engl J Med; 2004 Jul; 351(3):241-9. PubMed ID: 15254282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy.
    Dietrich JW; Gieselbrecht K; Holl RW; Boehm BO
    Horm Metab Res; 2006 Jan; 38(1):57-9. PubMed ID: 16477543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.